Bosh sahifa2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Yopilish kursi
13,42 $
Kunlik diapazon
13,42 $ - 13,68 $
Yillik diapazon
11,32 $ - 21,25 $
Bozor kapitalizatsiyasi
59,49 mlrd HKD
Oʻrtacha hajm
6,80 mln
Narx/foyda
14,05
Dividend daromadliligi
2,21%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,16 mlrd | -6,56% |
Joriy xarajat | 4,10 mlrd | -8,74% |
Sof foyda | 609,73 mln | -38,22% |
Sof foyda marjasi | 6,00 | -33,92% |
Har bir ulushga tushum | — | — |
EBITDA | 1,64 mlrd | 1,81% |
Amaldagi soliq stavkasi | 22,80% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 15,02 mlrd | -6,45% |
Jami aktivlari | 113,75 mlrd | 5,93% |
Jami passivlari | 56,21 mlrd | 7,41% |
Umumiy kapital | 57,54 mlrd | — |
Tarqatilgan aksiyalar | 2,67 mlrd | — |
Narxi/balansdagi bahosi | 0,77 | — |
Aktivlardan daromad | 2,16% | — |
Kapitaldan daromad | 2,66% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 609,73 mln | -38,22% |
Operatsiyalardan naqd pul | 917,31 mln | 5,05% |
Sarmoyadan naqd pul | -1,19 mlrd | -768,33% |
Moliyadan naqd pul | 98,64 mln | -65,02% |
Naqd pulning sof oʻzgarishi | -151,74 mln | -115,96% |
Boʻsh pul | -1,85 mlrd | 45,37% |
Haqida
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
CEO
Tashkil etilgan
1994
Sayt
Xodimlar soni
40 370
